311 related articles for article (PubMed ID: 26561554)
1. Improving the recognition and diagnosis of opioid-induced constipation in clinical practice.
Gupta A
J Fam Pract; 2015 Oct; 64(10 Suppl 1):. PubMed ID: 26561554
[TBL] [Abstract][Full Text] [Related]
2. Opioid-induced constipation in chronic noncancer pain.
Weber HC
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
[TBL] [Abstract][Full Text] [Related]
3. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced constipation.
Gyawali B; Hayashi N; Tsukuura H; Honda K; Shimokata T; Ando Y
Scand J Gastroenterol; 2015; 50(11):1331-8. PubMed ID: 26061717
[TBL] [Abstract][Full Text] [Related]
5. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
Streicher JM; Bilsky EJ
J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
[TBL] [Abstract][Full Text] [Related]
6. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.
Spierings EL; Brewer RP; Rauck RL; Losch-Beridon T; Mareya SM
Pain Pract; 2017 Mar; 17(3):312-319. PubMed ID: 26990171
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
[TBL] [Abstract][Full Text] [Related]
9. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M
J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600
[TBL] [Abstract][Full Text] [Related]
10. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
Corsetti M; Tack J
Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
White WB; Kowey P; Diva U; Sostek M; Tummala R
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
[TBL] [Abstract][Full Text] [Related]
12. Treating Opioid-Induced Constipation in Older Adults: New Options.
Sani H; Mahan RJ
Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
[TBL] [Abstract][Full Text] [Related]
13. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
[TBL] [Abstract][Full Text] [Related]
14. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
Rauck RL
Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
[TBL] [Abstract][Full Text] [Related]
15. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.
Chokhavatia S; John ES; Bridgeman MB; Dixit D
Drugs Aging; 2016 Aug; 33(8):557-74. PubMed ID: 27417446
[TBL] [Abstract][Full Text] [Related]
16. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
[TBL] [Abstract][Full Text] [Related]
17. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
van Malderen K; Halawi H; Camilleri M
Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
[TBL] [Abstract][Full Text] [Related]
18. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
[TBL] [Abstract][Full Text] [Related]
19. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
[TBL] [Abstract][Full Text] [Related]
20. Current concepts in the management of opioid-induced constipation.
Walters JB; Montagnini M
J Opioid Manag; 2010; 6(6):435-44. PubMed ID: 21269005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
